Titre:
  • A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer.
Auteur:Oettle, H; Richards, D.; Ramanathan, R K; Van Laethem, Jean-Luc; Peeters, Marc; Fuchs, M; Zimmermann, A; John, W; Von Hoff, D D; Arning, M; Kindler, H L
Informations sur la publication:Annals of oncology, 16, 10, page (1639-1645)
Statut de publication:Publié, 2005-10
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Gemcitabine
Pancreatic cancer
Pemetrexed
Phase III
Survival
MeSH keywords:Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Deoxycytidine -- administration & dosage -- analogs & derivatives -- therapeutic use
Female
Glutamates -- administration & dosage
Guanine -- administration & dosage -- analogs & derivatives
Humans
Infusions, Intravenous
Male
Middle Aged
Neoplasm Metastasis
Neutropenia -- chemically induced
Pancreatic Neoplasms -- drug therapy -- pathology
Survival Analysis
Treatment Outcome
Note générale:Clinical Trial, Phase III
Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0923-7534
info:doi/10.1093/annonc/mdi309
info:pii/mdi309
info:scp/27144530079
info:pmid/16087696